Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Usefulness of Procalcitonin Serum Level for the Diagnosis of Bacteremia
Authors
S. Liaudat
E. Dayer
G. Praz
J. Bille
N. Troillet
Publication date
01-08-2001
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2001
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s100960100548

Other articles of this Issue 8/2001

European Journal of Clinical Microbiology & Infectious Diseases 8/2001 Go to the issue

Brief Report

Rapid Identification of Streptococcus pneumoniae in Blood Cultures Using a Latex Agglutination Assay

Concise Article

Reduced Detection of Chlamydia trachomatis by the Ligase Chain Reaction Assay due to Suboptimal Storage of Urine

Article

Evaluation of a New Chromogenic Medium for the Isolation and Presumptive Identification of Salmonella Species from Stool Specimens

Concise Article

Two Cases of Pyomyositis Caused by Klebsiella pneumoniae and Review of the Literature

Article

Molecular Monitoring of Candida albicans Infections in Liver Transplant Recipients

Concise Article

Diagnosis of Catheter-Related Bloodstream Infections: Is it Necessary to Culture the Subcutaneous Catheter Segment?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits